75 related articles for article (PubMed ID: 9759628)
1. Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on platelets.
Lévy-Toledano S; Maclouf J; Rosa JP; Gallet C; Vallès G; Nurden P; Nurden AT
Thromb Haemost; 1998 Sep; 80(3):463-8. PubMed ID: 9759628
[TBL] [Abstract][Full Text] [Related]
2. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
3. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
[TBL] [Abstract][Full Text] [Related]
4. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin modulates platelet activation in vitro through protein-tyrosine phosphorylation.
Kubota Y; Arai T; Tanaka T; Yamaoka G; Kiuchi H; Kajikawa T; Kawanishi K; Ohnishi H; Yamaguchi M; Takahara J; Irino S
Stem Cells; 1996 Jul; 14(4):439-44. PubMed ID: 8843545
[TBL] [Abstract][Full Text] [Related]
6. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
7. Platelets possess functional TGF-beta receptors and Smad2 protein.
Lev PR; Salim JP; Marta RF; Osorio MJ; Goette NP; Molinas FC
Platelets; 2007 Feb; 18(1):35-42. PubMed ID: 17365852
[TBL] [Abstract][Full Text] [Related]
8. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
9. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
[TBL] [Abstract][Full Text] [Related]
10. Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib.
Diaz-Ricart M; Fuste B; Estebanell E; Tonda R; Lozano M; Escolar G; Jamieson G; Ordinas A
Platelets; 2005 Dec; 16(8):453-61. PubMed ID: 16287612
[TBL] [Abstract][Full Text] [Related]
11. Phosphotyrosine proteins in platelets from patients with storage pool disease: direct relation between granule defects and defective signal transduction.
Arderiu G; Díaz-Ricart M; Domenech P; Escolar G; Ordinas A; Pujol-Moix N
Haematologica; 2002 Jun; 87(6):629-36. PubMed ID: 12031920
[TBL] [Abstract][Full Text] [Related]
12. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
Pampuch A; Cerletti C; de Gaetano G
Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
[TBL] [Abstract][Full Text] [Related]
13. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
Rozalski M; Nocun M; Watala C
Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
[TBL] [Abstract][Full Text] [Related]
14. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
[TBL] [Abstract][Full Text] [Related]
15. A new role for FcgammaRIIA in the potentiation of human platelet activation induced by weak stimulation.
Canobbio I; Stefanini L; Guidetti GF; Balduini C; Torti M
Cell Signal; 2006 Jun; 18(6):861-70. PubMed ID: 16169188
[TBL] [Abstract][Full Text] [Related]
16. Regulation of postaggregation events induced by protease-activated receptor 1 ligation in human platelets: evidence of differential signaling pathways.
Ramars AS; Mukhopadhyay S; Dash D
Arch Biochem Biophys; 2002 Feb; 398(2):253-60. PubMed ID: 11831857
[TBL] [Abstract][Full Text] [Related]
17. Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.
Schweigel H; Geiger J; Beck F; Buhs S; Gerull H; Walter U; Sickmann A; Nollau P
Proteomics; 2013 Mar; 13(6):1016-27. PubMed ID: 23322602
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.
Jarvis GE; Atkinson BT; Snell DC; Watson SP
Br J Pharmacol; 2002 Sep; 137(1):107-17. PubMed ID: 12183336
[TBL] [Abstract][Full Text] [Related]
19. Modulation of platelet activation in vitro by thrombopoietin.
Kojima H; Hamazaki Y; Nagata Y; Todokoro K; Nagasawa T; Abe T
Thromb Haemost; 1995 Dec; 74(6):1541-5. PubMed ID: 8772234
[TBL] [Abstract][Full Text] [Related]
20. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
